Publication Name	World Journal of Gastroenterology
Manuscript ID	10300
Country	China

Received	2014-03-26 09:32
Peer-Review Started	2014-03-26 21:12
First Decision by Editorial Office Director
Return for Revision	2014-05-03 19:34
Revised	2014-05-14 20:34
Publication Fee Transferred
Second Decision by Editor	2014-07-16 17:11
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2014-07-16 17:31
Articles in Press	2014-07-16 17:49
Edit the Manuscript by Language Editor	2014-07-28 16:35
Typeset the Manuscript	2014-10-15 20:00
Publish the Manuscript Online	2014-10-29 19:34

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation
Manuscript Source	Unsolicited Manuscript
All Author List	Xing-Chun Wang, Aaron M Gusdon, Huan Liu and Shen Qu
Funding Agency and Grant Number
Corresponding Author	Shen Qu, Professor, Department of Endocrinology and Metabolism, Shanghai 10th People’s Hospital, Tongji University, 301 Middle Yanchang Road, Shanghai 200072, China. qushencn@hotmail.com
Key Words	Glucagon-like peptide-1 receptor agonists; Liver function; Fat content; Non-alcoholic fatty liver disease; Inflammation
Core Tip	The findings showed that glucagon-like peptide-1 receptor agonists (GLP-1RAs) may improve liver function, fat content and distribution, lipid metabolism and reduce the activity of inflammatory cytokines and their associated signal transduction pathways. Thus, we review here that GLP-1RAs are a potential method for pharmacologic treatment that can benefit patients with non-alcoholic fatty liver disease and chronic inflammation.
Publish Date	2014-10-29 19:34
Citation	Wang XC, Gusdon AM, Liu H, Qu S. Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation. World J Gastroenterol 2014; 20(40): 14821-14830
URL	http://www.wjgnet.com/1007-9327/full/v20/i40/14821.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i40.14821

Full Article (PDF)	WJG-20-14821.pdf
Full Article (Word)	WJG-20-14821.doc
Manuscript File	10300-Review.docx
Answering Reviewers	10300-Answering reviewers.pdf
Copyright License Agreement	10300-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	10300-Language certificate.pdf
Peer-review Report	10300-Peer review.pdf
Scientific Misconduct Check	10300-CorssCheck.jpg
Scientific Editor Work List	10030-Scientific editor work list.pdf